# Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function

> **NCT00137475** · PHASE1,PHASE2 · COMPLETED · sponsor: **AHS Cancer Control Alberta** · enrollment: 130 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **PROCEDURE:** Intensity-Modulated Radiation Therapy

## Key facts

- **NCT ID:** NCT00137475
- **Lead sponsor:** AHS Cancer Control Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 130 (ACTUAL)
- **Last updated:** 2016-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00137475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00137475, "Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00137475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*